Silence Therapeutics (SLN) Intangibles (2018 - 2026)
Silence Therapeutics (SLN) posted Intangibles of $248000.0 for Q1 2026, down 13.89% sequentially from $288000.0 in Q4 2025, and down 20.0% YoY from $310000.0 in Q1 2025.
Silence Therapeutics (SLN) Intangibles (2018 - 2026) Analysis & Trends
Silence Therapeutics has reported Intangibles for 9 years, with the latest figure at $248000.0 in Q1 2026.
- Quarterly Intangibles fell 20.0% year-over-year to $248000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248000.0 (down 20.0% YoY) and the FY2025 annual result came in at $288000.0, down 7.69% from the prior year.
- Intangibles slipped to $248000.0 in Q1 2026 per SLN's latest filing, from $288000.0 in the prior quarter.
- Over five years, Intangibles peaked at $375337.1 in Q4 2022 and troughed at $248000.0 in Q1 2026.
- A 5-year average of $312853.0 and a median of $311000.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2026: Intangibles soared 114.18% in 2022, then dropped 20.0% in 2026.
- Over 5 years, Intangibles stood at $375337.1 in 2022, then declined by 6.09% to $352487.1 in 2023, then fell by 11.49% to $312000.0 in 2024, then slipped by 7.69% to $288000.0 in 2025, then dropped by 13.89% to $248000.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $248000.0, $288000.0, and $300000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | 237,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 237,000.00 |
| Mar 31, 2026 | 248,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 310,000.00 |
| Dec 31, 2024 | 312,000.00 |
| Dec 31, 2023 | 352,487.14 |
| Dec 31, 2022 | 375,337.06 |
| Dec 31, 2021 | 175,241.38 |
| Dec 31, 2020 | 118,840.59 |
| Dec 31, 2019 | 131,143.94 |
| Dec 31, 2018 | 82,353.10 |